Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome
- 26 July 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 31 (10), 1401-1408
- https://doi.org/10.1007/s00134-005-2736-8
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profilePharmacology & Therapeutics, 2004
- Assessing the Usefulness of Anticardiolipin Antibody AssaysAmerican Journal of Clinical Pathology, 2002
- Structure ofCampylobacter jejuniLipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher PatientsInfection and Immunity, 2002
- New Concepts of Guillain-Barré SyndromeJournal of Child Neurology, 2000
- Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain–Barré syndromeJournal of Neuroimmunology, 2000
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996
- Demonstration that anti-phospholipid auto-antibodies react with both anionic and zwitterionic phospholipidsImmunology Letters, 1993
- Autoantibodies Against All teh Phospholipids: A Comparative Systematic Study with Syatemic Lupus Erythematosus and Healthy Seracclm, 1991
- Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies.Annals Of The Rheumatic Diseases, 1985
- Role of infection in Guillain-Barré syndrome: Laboratory confirmation of herpesviruses in 41 casesAnnals of Neurology, 1981